Further, HER2− tumors have even been documented to give rise to HER2+ brain metastases while maintaining a global HER2− state at the primary tumor and other secondary sites, emphasizing the strong selective advantage of HER2+ breast cancer cells possess to colonize the brain (131, 132). Here, ERBB2 is linked to breast carcinoma.